Role of the target organ in determining susceptibility to experimental autoimmune myasthenia gravis. 1998

A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
Maastricht University, Department of Immunology, The Netherlands.

Injection of anti-AChR antibodies in passive transfer experimental autoimmune myasthenia gravis (EAMG) results in increased degradation of acetylcholine receptor (AChR) and increased synthesis of AChR alpha-subunit mRNA. Passive transfer of anti-Main Immunogenic Region (MIR) mAb 35 in aged rats does not induce clinical signs of disease nor AChR loss. The expression of the AChR subunit genes was analyzed in susceptible and resistant rats. In aged EAMG resistant rats, no increase in the amount of AChR alpha-subunit mRNA was measured. In vivo AChR degradation experiments did not show any increase in AChR degradation rates in aged resistant rats, in contrast to young susceptible rats. Taken together, these data demonstrate that resistance of the AChR protein to antibody-mediated degradation is the primary mechanism that accounts for the resistance to passive transfer EAMG in aged rats.

UI MeSH Term Description Entries
D009121 Muscle Denervation The resection or removal of the innervation of a muscle or muscle tissue. Denervation, Muscle,Denervations, Muscle,Muscle Denervations
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D011914 Rats, Inbred BN An inbred strain of rat that is widely used in a variety of research areas such as the study of ASTHMA; CARCINOGENESIS; AGING; and LEUKEMIA. Rats, Inbred Brown Norway,Rats, BN,BN Rat,BN Rat, Inbred,BN Rats,BN Rats, Inbred,Inbred BN Rat,Inbred BN Rats,Rat, BN,Rat, Inbred BN
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
December 2012, Annals of the New York Academy of Sciences,
A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
May 1998, Annals of the New York Academy of Sciences,
A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
January 1988, Monographs in allergy,
A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
July 1980, Journal of neurology, neurosurgery, and psychiatry,
A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
May 2000, Clinical immunology (Orlando, Fla.),
A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
September 1997, Muscle & nerve,
A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
January 1994, Advances in neuroimmunology,
A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
May 1998, Journal of immunology (Baltimore, Md. : 1950),
A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
January 1978, Muscle & nerve,
A Hoedemaekers, and J L Bessereau, and Y Graus, and T Guyon, and J P Changeux, and S Berrih-Aknin, and P van Breda Vriesman, and M H De Baets
April 1978, The Journal of experimental medicine,
Copied contents to your clipboard!